Icl accelerating biologicals portfolio growth in brazil with strategic acquisition

Tel aviv, israel--(business wire)--icl (nyse: icl) (tase: icl), a leading global specialty minerals company, today announced it has acquired nitro 1000, a manufacturer, developer and provider of biologicals in brazil for approximately $30 million. this acquisition marks another meaningful step into the biologicals market, while expanding icl's product offerings and positioning the company for further expansions into new and adjacent end-markets. nitro 1000 will immediately join the icl product.
ICL Ratings Summary
ICL Quant Ranking